
|Articles|August 31, 2011
T-Cell and B-Cell Targeting Agents in Rheumatoid Arthritis
In a Cleveland Clinic video, William Rigby, MD, of Dartmouth Medical School, discusses B-cell and T-cell-directed therapy for rheumatoid arthritis.
Advertisement
In this video from the Cleveland Clinic, William Rigby, MD, professor and vice-chair of medicine at Dartmouth Medical School, discusses B-cell and T-cell-directed therapy for rheumatoid arthritis.
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Advertisement
Advertisement
Advertisement
Trending on CGTlive®
1
M. Peter Marinkovich, MD, on Integrating Gene Therapy into Clinical Practice for Dermatologists
2
Quarter Century Update: Platform Approaches and Industry Investment
3
Quarter Century Update: How can Partnerships Between Academia, Biotech, and Pharma be Better Structured?
4











































